Healthcare Services

Gastric Volvulus Treatment Market: Trends and Expansion Potential

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Gastric Volvulus Treatment Market From 2026 To 2030?

The market for gastric volvulus treatment has shown robust expansion in recent years. This market is projected to expand from $28.86 billion in 2025 to $30.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as the accessibility of surgical treatment options, the rise in hospital emergency care, improved diagnosis via imaging tests, the evolution of gastropexy procedures, and advancements in surgical expertise.

The gastric volvulus treatment market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $39.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. Key drivers for this growth during the forecast period include the rise in minimally invasive surgical procedures, enhancements in emergency response systems, the uptake of advanced imaging technologies, the proliferation of specialized surgical centers, and a heightened level of clinical awareness. Significant trends observed over the forecast duration encompass a growing inclination towards surgical interventions, wider acceptance of minimally invasive techniques, better emergency diagnosis and management protocols, the broadening of specialized surgical care, and an emphasis on prompt treatment to decrease mortality rates.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Which Primary Drivers Are Impacting The Gastric Volvulus Treatment Market Growth?

The increasing number of older adults is projected to stimulate expansion in the gastric volvulus treatment market moving ahead. This demographic comprises individuals aged 65 years and beyond, who often experience diverse health issues resulting from diminished immunity and the aging process. Gastric volvulus specifically manifests in adults who are older than 50. Consequently, an increase in the geriatric population is anticipated to boost the market. As an illustration, data from January 2024, released by the Population Reference Bureau (PRB), a US-based nonprofit organization, indicates a projected rise in Americans aged 65 and older from 58 million in 2022 to 82 million by 2050, marking a 47% increase, and their representation within the total population is expected to grow from 17% to 23%. Thus, the growing number of geriatric individuals is acting as a key driver for the gastric volvulus treatment market.

What Are The Key Segment Divisions In The Gastric Volvulus Treatment Market Segment Structure?

The gastric volvulus treatment market covered in this report is segmented –

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus

2) By Treatment Type: Medication, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy

2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques

Which Trends Are Shaping Growth In The Gastric Volvulus Treatment Market?

Leading companies in the gastric volvulus treatment market are concentrating on developing innovative solutions, such as next-generation oral immunomodulatory therapies, to address the growing demand for advanced treatment options that enhance long-term disease management and patient quality of life. These orally administered therapies specifically target inflammatory and immune-driven mechanisms, providing a more convenient and precise alternative when compared with traditional systemic treatments, which may involve greater side-effect risks and require more intensive management. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator intended for individuals with moderate to severe active ulcerative colitis (UC). VELSIPITY’s official suggested dosage is 2 mg. VELSIPITY allows adults with moderately to severely active UC to achieve steroid-free resolution with an oral, once-daily pill that demonstrates a positive benefit-risk profile. The FDA’s approval of VELSIPITY today represents an important turning point for UC patients who require novel therapies for this long-term illness and are ready to commence advanced treatment.

Which Organizations Are Engaged In The Gastric Volvulus Treatment Market?

Major companies operating in the gastric volvulus treatment market are Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, TransEnterix Inc.

Get The Full Gastric Volvulus Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Which Geographic Region Dominates The Gastric Volvulus Treatment Market?

North America was the largest region in the gastric volvulus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gastric Volvulus Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Browse Through More Reports Similar to the Global Gastric Volvulus Treatment Market 2026, By The Business Research Company

Gastric Ulcers Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Gastroparesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Gas Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/gas-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795